A method comprising detecting an epileptic event in a patient; applying an electrical therapy to a first target area in at least one of a brain region or a cranial nerve of said patient in response to said detecting; receiving a body signal responsive to the electrical therapy, wherein said body signal is selected from an autonomic signal, a neurologic signal, a metabolic signal, an endocrine signal, or a tissue stress marker signal; determining whether said body signal indicates that said electrical therapy has an efficacious effect; and terminating the application of said electrical therapy if the response indicates that the electrical therapy has an efficacious effect. An apparatus capable of performing the method. A non-transitive, computer-readable storage device for storing data that when executed by a processor, perform the method.

Gamma brain stimulation (around 40 Hz) is performed using light pulses. To perform theta brain stimulation (around 7 Hz) without perceptible flicker, the light source is also strobed at 47 Hz (also within the gamma range). The brain perceives the 40 Hz and a subtraction frequency of 7 Hz (in the theta range). The combined gamma and theta wave stimulation of the brain may be used for preventing or treating brain disease or sleeping disorders. The particular stimulation frequencies and their phases create neuronal gamma-theta coupling in the brain that has been shown to have positive effects on memory, Alzheimer's disease, motor skills, and other functions. Other gamma and theta frequencies, creating gamma-theta coupling in the brain, are also beneficial. The phase of the light pulses is also dynamically controlled using feedback to maximize theta-gamma coupling in the brain.

A novel photobiomodulation (PBM) system and method that comprehensively directs therapeutic light energy into the brain from a combination of transcranial (through the skull) and intranasal (via the nasal channels) locations. In a preferred embodiment, the PBM device works in combination with a diagnostic tool to provide enhanced treatment of abnormal brain function intelligently, automatically, and unrestricted by geographical distances.

The present wireless remote control device is a type of equipment with non-tethered optical stimulation. The characteristic of this device is designed to utilize a magnetic resonance technique to modify the deficits of the conventional magnetic induction or radio-frequency power source. Compared to the other devices of photostimulation, the advantages are as follow: there is a strong and even electromagnetic power; the cost is cheaper than the previous others; the device uses the receiver coil on an animal's head to receive the magnetic power from the transformation of the electrical power in the outside big coil, and thus the weight of the receiver coil on the head is very light. The light and miniaturized coil on the head without battery could give animals more convenience in freely movement, and the behavior of animals can be controlled by the effective extent of the electromagnetic field through photostimulation.

A method for optogenetics experiments, based on wavefront shaping and including: calculating the transmission matrix between an input end and an output end of the multimode fiber under a fixed shape; implanting the output end into an intracranial space of an experimental subject; and performing wavefront compensation to a light to be input into the input end, according to the spatial position of the optical stimulation and the transmission matrix of the multimode fiber, to form a compensated expanded light, and inputting the compensated expanded light from the input end into the multimode fiber, such that the compensated expanded light, after being transmitted by the multimode fiber to the output end and output from the output end, is capable of focusing at the spatial position of the optical stimulation.

A photobiomodulation (PBM) device including eyewear (e.g., incorporating prescription or non-prescription lenses) that is worn throughout the day is provided. The PBM device provides longer-term light delivery throughout the day and may capture patient compliance, provide real-time dose adjustments, and allow for HIPAA-compliant communication with the prescribing clinician. The PBM device provides a wearable, open eye device format designed for increased compliance, lower cost, and greater convenience.

A device for enhancement of visual appearance including a first applicator to be coupled to a first area of a body region, with a first magnetic field generating device and a first radiofrequency electrode, a second applicator to be coupled to a second area of the body region, with a second magnetic field generating device. The device further includes a first energy storage device, a second energy storage device, and a first switching device to discharge energy from the first energy storage device to the first magnetic field generating to generate a first time-varying magnetic field to cause muscle contraction, and a second switching to discharge energy from the second energy storage device to the second magnetic field generating device to generate a second time-varying magnetic field. The first radiofrequency electrode may provide first radiofrequency waves causing heating of tissue within the first area of the body region.

A photobiomodulation system includes a) a control module having electronic subassembly disposed in a housing, a connector coupled to the housing and defining a connector lumen, and at least one light source to produce light in response to signals from the electronic subassembly; b) a lead coupled or coupleable to the control module and having a lead body defining a lead lumen and at least one opening along a distal portion of the lead, light emitters arranged along the distal portion of the lead, and optical fibers extending along the lead body and coupled to the light emitters; and c) a catheter assembly having a tube coupleable to a catheter pump, and a distal connector attached to the end of the tube and coupled or coupleable to the connector of the control module.

Methods, systems, and compositions are provided for implanting an implantable device into a biological tissue (e.g., muscle, brain). A subject implantable device includes: (i) a biocompatible substrate, (ii) a conduit (e.g., an electrode, a waveguide) that is disposed on the biocompatible substrate, and (iii) an engagement feature (e.g., a loop) for reversible engagement with an insertion needle. The biocompatible substrate can be flexible (e.g., can include polyimide). The implantable device is implanted using an insertion needle that includes an engagement feature corresponding to the engagement feature of the implantable device. To implant, an implantable device is reversibly engaged with an insertion needle, the device-loaded insertion needle is inserted into a biological tissue (e.g., to a desired depth), and the insertion needle is retracted, thereby disengaging the implantable device from the insertion needle and allowing the implantable device to remain implanted in the biological tissue.

A medical apparatus and method of operating a medical apparatus are disclosed. The apparatus includes a radiation source for emitting electromagnetic radiation towards one or both eyes of a patient; wherein the apparatus is configured to emit electromagnetic radiation having a ratio of scotopic luminous intensity to photopic luminous intensity of at least 1.85:1.